Biology subjects

Pink, A.

Publications and source records attributed to Pink, A..

3 recordsLinked to original sources

bioRxiv2026

Integrin-independent Tie2 activation using de novo designed proteins

The Angiopoietin-Tie2 pathway is a key regulator of vascular stability, but therapeutic exploitation has been limited by the poor developability of Angiopoietin-1 (Ang1), and there are key unresolved mechanistic questions. Ang1 binds both Tie2 and 5{beta}1 integrin, and the role of the 5{beta}1 interaction in signaling has been unclear. We used RFdiffusion to design a stable, high-affinity Tie2 minibinder that has no affinity for 5{beta}1. The binder is a selective antagonist in monomeric form, and a potent agonist when assembled into an octavalent architecture (H8mb) which drives Tie2 clustering. H8mb signals as potently as Ang1, indicating that integrin engagement is not required for Tie2 activation. However, the duration of signaling is reduced, and internalization of H8mb-Tie2 complexes is more rapid, suggesting that integrin may function as a co-receptor for Ang1 that prolongs signaling by extending the lifetime of the receptor ligand complex on the cell surface. In a mouse model of acute respiratory distress syndrome (ARDS), H8mb markedly improved survival. These results demonstrate that de novo designed receptor binders can enable dissection of co-receptor control of signaling dynamics, and the more stable and manufacturable H8mb provides routes to more developable therapeutic candidates.

biochemistry↗

bioRxiv2026

Scaffold protein SHANK3 regulates endothelial cell motility and tissue mechanics

SHANK3 is a multidomain scaffolding protein critical for neuronal function, which has been linked to neurodevelopmental disorders such as autism spectrum disorder. More recently, SHANK3 has been shown to play a role in cell survival and actin dynamics outside the nervous system. Here, we show that SHANK3 is widely expressed in endothelial cells across different tissues, where its role is not well understood. SHANK3 localised to endothelial cell-cell junctions in cultured endothelial cells, and its depletion compromised endothelial barrier function. SHANK silencing altered cell mechanics including elongated cell morphology, reduced cell-matrix traction forces and alteration of cell migration rate. It further triggered dynamic heterogeneity in endothelial monolayers, with regions of coordinated long-range migration interspersed with areas exhibiting only local velocity fluctuations, consistent with a transition toward more fluid-like tissue behaviour. This change in collective dynamics was accompanied by increased spheroid spreading and fusion, suggestive of altered tissue viscosity, and coincided with disrupted cell-cell junction morphology and mechanical forces in SHANK3-depleted cells. In vivo, SHANK3 depletion impaired endothelial cell migration, resulting in delayed sprouting of intersegmental vessels and disruption of the vascular network in zebrafish embryos. Furthermore, inducible endothelial-specific deletion of SHANK3 in postnatal mice impaired angiogenic sprouting and reduced vascular complexity in the developing retina. Overall, we demonstrate that SHANK3 plays a role in endothelial cell motility and tissue mechanics, with implications for vascular processes during development.

cell biology↗

bioRxiv2023

DLL4-Notch3-WNT5B axis is a novel mediator of bi-directional pro-metastatic crosstalk between melanoma and lymphatic endothelial cells

Despite strong indications that melanoma interaction with lymphatic vessels actively promotes melanoma progression, the molecular mechanisms are not yet completely understood. To characterize molecular factors of this crosstalk we established human primary lymphatic endothelial cell (LEC) co-cultures with human melanoma cell lines. Here, we show that co-culture with melanoma cells induced transcriptomic changes in LECs and led to multiple alterations in their function. WNT5B, a paracrine signaling molecule upregulated in melanoma cells upon LEC interaction, was found contributing to the functional changes in LECs. Moreover, WNT5B transcription was regulated by Notch3 in melanoma cells following the co-culture with LECs, and Notch3 and WNT5B were co-expressed in melanoma patient primary tumor and metastasis samples. Moreover, melanoma cells derived from LEC co-culture escaped efficiently from the primary site to the proximal tumor draining lymph nodes, which was impaired upon WNT5B depletion. This supports the role of WNT5B in promoting the metastatic potential of melanoma cells through its effects on LECs. Finally, DLL4, a Notch ligand expressed in LECs, was identified as an upstream inducer of the Notch3-WNT5B axis in melanoma. This study elucidates WNT5B as a novel molecular factor mediating bi-directional crosstalk between melanoma cells and lymphatic endothelium and promoting melanoma metastasis.

cancer biology↗